[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359182-105":59,"doc-detail-359182-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteogenomic-characterization-delineates-clinically-relevant-subtypes-of-advanced-differentiated-thyroid-cancer","Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer","","Advanced differentiated thyroid cancer (DTC) remains difficult to treat, with limited therapeutic options and poor outcomes for patients who progress to advanced disease. The study performs proteogenomic analysis of 113 advanced DTC cases to define three molecularly distinct subtypes—canonical, stromal, and immunogenic—each differing in driver mutations, histopathology, and clinical endpoints. A machine-learning classifier predicts these subtypes using routine gene mutation and digital pathology data and is validated in independent cohorts with single-cell and spatial transcriptomics, supported by evidence from a real-world treatment cohort.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteogenomic-characterization-delineates-clinically-relevant-subtypes-of-advanced-differentiated-thyroid-cancer/359182/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteogenomic-characterization-delineates-clinically-relevant-subtypes-of-advanced-differentiated-thyroid-cancer/359182.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in advanced differentiated thyroid cancer?","Question",{"text":112,"@type":113},"Advanced DTC has limited therapeutic options and unfavorable prognosis once patients progress to locally advanced or metastatic disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many molecular subtypes of advanced DTC are identified, and what are they?",{"text":117,"@type":113},"The analysis identifies three molecularly distinct subtypes: canonical, stromal, and immunogenic.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the subtyping framework applied clinically?",{"text":121,"@type":113},"A machine-learning classifier predicts the proteomic subtypes using routinely available gene mutation and digital pathology data, and its biological and clinical relevance are validated in independent and real-world cohorts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359182,1791167219,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Article  \nProteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer  \nAuthors  \nTingting Zhang, Wangpeng Cui, Haitao Tang, ..., Wenjun Wei, Yu Wang, Xiao Shi  \nCorrespondence  \n[xingsun@hotmail.com](xingsun@hotmail.com) (X.S.),  \n[jq_hai@126.com](jq_hai@126.com) (Q.J.),  \n[wenjunweifdu@163.com](wenjunweifdu@163.com) (W.W.),  \n[neck130@sina.com](neck130@sina.com) (Y.W.),  \n[xshi11@fudan.edu.cn](xshi11@fudan.edu.cn) (X.S.)  \nIn brief  \nZhang et al. systematically reveal the heterogeneity of advanced differentiated thyroid cancer (DTC) from a biological perspective and develop a genomicspathomics model that provides a preliminary basis for a therapeutic framework to advance precision oncology in this disease.  \n• Three proteomic subtypes of advanced DTC show distinct molecular and clinical features  \n• Establishment of an accurate model to predict proteomic subtypes of advanced DTC  \n• Real-world cohort explores clinical relevance of molecular subtypes in advanced DTC  \nZhang et al., 2026, Cell Reports Medicine 7, 102661  \nMarch 17, 2026 © 2026 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102661](https://doi.org/10.1016/j.xcrm.2026.102661)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nProteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer  \nTingting Zhang,1,2,12 Wangpeng Cui,1,2,12 Haitao Tang,1,2,12 Cenkai Shen,1,2,12 Yan Zhang,2,3,12 Yaoting Sun,4 Yan Zhou,4 Chentian Shen,5 Huajun Xu,6 Chenyi Wang,7 Wenyang Ding,8 Fuxing Zheng,8 Tiansheng Xu,8 Chuqiao Liu,1,2 Yuxin Du,1,2 Zhiyan Liu,9 Yulong Wang,1,2 Naisi Huang,1,2 Xiaoqi Mao,1,2 Dongmei Ji,2,10 Xing Sun,11,* Qinghai Ji,1,2,* Wenjun Wei,1,2,* Yu Wang,1,2,* and Xiao Shi1,2,13,*  \n1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China  \n2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China  \n3Department of Pathology, Shanghai Medical College, Fudan University, Shanghai 200032, China  \n4Westlake Center for Intelligent Proteomics, School of Life Sciences, Westlake University, Hangzhou 310024, China  \n5Department of Nuclear Medicine, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China  \n6Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China  \n7Department of Ultrasound, China-Japan Friendship Hospital, Beijing 100029, China  \n8Shanghai OE Biotech Co. , Ltd, Shanghai 201112, China  \n9Department of Pathology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China  \n10Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China  \n11Department of General Surgery, Shanghai General Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China  \n12These authors contributed equally  \n13Lead contact  \n*[Correspondence:](Correspondence: xingsun@hotmail.com)[ xingsun@hotmail.com](Correspondence: xingsun@hotmail.com) (X.S.), [jq_hai@126.com](jq_hai@126.com) (Q.J.), [wenjunweifdu@163.com](wenjunweifdu@163.com) (W.W.), [neck130@sina.com](neck130@sina.com) (Y.W.), xshi11@ [fudan.edu.cn](fudan.edu.cn) (X.S.)  \n[https://doi.org/10.1016/j.xcrm.2026.102661](https://doi.org/10.1016/j.xcrm.2026.102661)  \nSUMMARY  \nAdvanced differentiated thyroid cancer (DTC) is characterized by limited therapeutic options and unfavorable prognosis. To address this, we conduct proteogenomic analysis of 113 advanced DTCs, identifying three molecularly distinct subtypes: canonical, stromal, and immunogenic. These subtypes exhibit differences in driver mutations, histopathological features, and clinical outcomes. Based on their unique biology, we suggest distinct therapeutic strategies for","cbCaie2QHC3B5rFs","https://ap.wps.com/l/cbCaie2QHC3B5rFs","pdf",20435090,25,"English","# Summary\n# Introduction\n## Rationale for studying advanced DTC\n## Current treatment landscape and limitations","[{\"question\":\"What problem does the study address in advanced differentiated thyroid cancer?\",\"answer\":\"Advanced DTC has limited therapeutic options and unfavorable prognosis once patients progress to locally advanced or metastatic disease.\"},{\"question\":\"How many molecular subtypes of advanced DTC are identified, and what are they?\",\"answer\":\"The analysis identifies three molecularly distinct subtypes: canonical, stromal, and immunogenic.\"},{\"question\":\"How is the subtyping framework applied clinically?\",\"answer\":\"A machine-learning classifier predicts the proteomic subtypes using routinely available gene mutation and digital pathology data, and its biological and clinical relevance are validated in independent and real-world cohorts.\"}]","Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer | PDF",1790136348,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b250ed1862be26ffee100c042a38adb4.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6b30e1d558550f50b7768c08d4dac92.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ef4316ad9694b37cc43c182d8d9ceeb.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b10b883519e09d518f80b4697938610.webp",980,1272]